Healthequity Stock News

HealthEquity, Inc. (NASDAQ:HQY) Equities research analysts at Barrington Research reduced their Q4 2022 earnings estimates for HealthEquity in a research note issued on Tuesday, December 7th. Barrington Research analyst A. Paris. Jr now expects that the company will earn $0.05 per share for the quarter, down from their previous estimate of $0.22. Barrington Research []

HealthEquity, Inc. (NASDAQ:HQY) Director Stuart B. Parker acquired 25,000 shares of HealthEquity stock in a transaction dated Thursday, December 9th. The shares were acquired at an average price of $42.82 per share, with a total value of $1,070,500.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through []

HealthEquity, Inc. (NASDAQ:HQY) Investment analysts at Barrington Research decreased their FY2022 earnings per share (EPS) estimates for shares of HealthEquity in a report issued on Tuesday, December 7th. Barrington Research analyst A. Paris. Jr now expects that the company will post earnings per share of $0.80 for the year, down from their previous forecast []

AVAV, HQY, MESA, SWK, and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 10, 2021.

AVAV, HQY, MESA, SWK, and CGNX have been added to the Zacks Rank #5 (Strong Sell) List on December 10, 2021.

HealthEquity (NASDAQ:HQY) had its target price decreased by Barrington Research from $80.00 to $55.00 in a research report sent to investors on Tuesday, The Fly reports. Barrington Research currently has an outperform rating on the stock. Barrington Research also issued estimates for HealthEquitys FY2022 earnings at $0.80 EPS. Other research analysts have also recently issued []

HealthEquity (NASDAQ:HQY) had its price objective lowered by analysts at Deutsche Bank Aktiengesellschaft from $75.00 to $52.00 in a research note issued to investors on Wednesday, The Fly reports. The firm currently has a buy rating on the stock. Deutsche Bank Aktiengesellschafts price objective would suggest a potential upside of 23.60% from the stocks current []

TheStreet downgraded shares of HealthEquity (NASDAQ:HQY) from a c rating to a d+ rating in a research note released on Tuesday morning, TheStreetRatingsTable reports. Other equities research analysts have also recently issued research reports about the company. Barrington Research dropped their price objective on HealthEquity from $80.00 to $55.00 and set an outperform rating on []

Investors are optimistic about Align Technology's (ALGN) better-than-expected results and growing uptake of iTero scanners in the third quarter of fiscal 2021.

The receipt of the Health Canada license for Medtronic's (MDT) Hugo RAS System is likely to enhance accessibility to robotic-assisted surgery in Canada.

HealthEquity (NASDAQ:HQY) had its price objective reduced by Royal Bank of Canada from $87.00 to $70.00 in a research note released on Tuesday morning, The Fly reports. They currently have an outperform rating on the stock. HQY has been the topic of several other reports. SVB Leerink raised shares of HealthEquity from a market perform []

HealthEquity, Inc. (NASDAQ:HQY)s stock price gapped down prior to trading on Tuesday after Barrington Research lowered their price target on the stock from $80.00 to $55.00. The stock had previously closed at $56.67, but opened at $41.25. Barrington Research currently has an outperform rating on the stock. HealthEquity shares last traded at $40.50, with a []

NEW YORK - Stocks that traded heavily or had substantial price changes Tuesday: Intel Corp., up $1.58 to $52.57. The chipmaker said it plans to take its Mobileye self-driving